Blood Processing Devices And Consumables Market Size, Share & Trends Analysis Report By Product (Devices, Consumables), By End-use (Hospitals & Clinics, Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The global blood processing devices and consumables market size was valued at USD 51.6 billion in 2024 and is anticipated to grow at a CAGR of 7.1% from 2025 to 2030. This growth is attributed to the rising prevalence of infectious diseases necessitating increased blood transfusions and surgical interventions, while an aging population increases the demand for medical processes requiring blood. In addition, technological advancements improve device performance, safety, and accuracy, thereby driving the market’s growth. Furthermore, increased healthcare expenditure and supportive government initiatives drive market growth, particularly in regions such as North America and Asia Pacific, where healthcare infrastructure is robust and developing.

Blood processing equipment is also used at diagnostic centers to diagnose disorders such as cancer and heart disease and in hospitals for blood transfusions. Refrigerators, cell processors, centrifuges, blood storage bags, blood collection tubes, and other reagents are used in blood processing. Blood transfusion and processing are required for various surgical procedures, stem cell therapies, and organ transplants, which is projected to drive the global blood processing devices and consumables market.

The global blood processing devices and consumables market is experiencing significant growth, driven by several consistent factors. The rise in blood transfusion-related disorders, such as sickle cell disease and thalassemia, necessitates regular blood transfusions, increasing the demand for effective blood screening tests and processing equipment. Moreover, the growing number of surgical procedures, particularly in orthopedics and cardiac care, further escalates the need for blood units from donors and banks.

Innovative research and advancements in life sciences are also contributing to market expansion by enhancing blood processing techniques. For example, studies have shown that specific proteins in the blood can help diagnose neurodegenerative diseases, highlighting the importance of efficient blood processing methods. Furthermore, blood processing devices in hospitals and blood banks ensure that donated blood is stored and managed effectively, mitigating risks associated with infectious diseases such as hepatitis and HIV.

As healthcare systems worldwide continue to evolve, the increasing focus on patient safety and preventing transfusion-transmitted infections (TTIs) is propelling the demand for advanced blood processing technologies.

Product Insights

Devices dominated the market and accounted for the largest revenue share of 60.8% in 2024 attributed to the increasing prevalence of infectious diseases and the aging population. In addition, the demand for advanced blood processing devices has surged as more patients require blood transfusions and surgical interventions. Furthermore, technological innovations have improved device performance, safety, and user-friendliness, enhancing their adoption in healthcare settings. Moreover, emphasizing blood safety and quality necessitates reliable devices for effective blood component separation and processing, contributing to market expansion.

The device segments are categorized into various sub-segments, such as cell processors, hematocrit centrifuges, blood bank refrigerators, blood bank freezers, grouping analyzers, and warmers. The cell processors led the segment and accounted for the largest revenue share in 2024 owing to the increasing blood donation rates, and the rising demand for efficient blood component separation significantly contributes to this trend. In addition, cell processors automate and enhance the separation process, reducing labor intensity and improving safety. Furthermore, technological advancements enable these devices to produce higher yields of viable cells, crucial for transfusions and therapeutic applications and expanding their usage in hospitals and blood banks.

Consumables are expected to grow at a CAGR of 7.2% over the forecast period, owing to rising healthcare expenditures and increased blood donation initiatives. In addition, the growing problem of chronic diseases necessitates frequent blood testing, which drives demand for consumables such as blood bags and collection tubes. Furthermore, government initiatives promoting blood donation have led to a surge in donor numbers, requiring efficient consumables for collection and storage.

End-use Insights

Hospitals and clinics led the market and accounted for the largest revenue share in 2024, attributed to the increasing prevalence of chronic diseases and surgical procedures. Hospitals invest in advanced blood processing technologies to enhance patient care as more patients require blood transfusions and related treatments. Furthermore, expanding healthcare infrastructure, particularly in developing regions, demands efficient blood collection and processing solutions. Moreover, government initiatives promoting blood donation further bolster this growth, ensuring hospitals can effectively meet rising healthcare needs.

Diagnostic Laboratories are expected to grow at a CAGR of 7.4% over the forecast period, owing to the rising demand for accurate and timely blood testing. In addition, the increasing incidence of infectious diseases and genetic disorders necessitates frequent testing, leading laboratories to adopt advanced blood processing devices and consumables. Furthermore, the push for point-of-care testing enhances accessibility, allowing for quicker diagnoses and treatment decisions, thereby expanding the role of diagnostic laboratories in the healthcare ecosystem.

Regional Insights

The North America blood processing devices and consumables market accounted for the largest revenue share of 39.5% in 2024, attributed to the advanced healthcare infrastructure and significant investments in medical technology. In addition, the region's focus on research and development fosters innovation in blood processing technologies. Furthermore, the increasing prevalence of chronic diseases necessitates more blood transfusions, thereby boosting demand. Moreover, favorable reimbursement policies encourage healthcare providers to adopt new devices and consumables, enhancing market growth prospects in this region.

U.S. Blood Processing Devices and Consumables Market Trends

The blood processing devices and consumables market in the U.S. is expected to grow at a significant revenue share over the forecast period driven by a high demand for blood processing devices due to the aging population and rising incidences of conditions requiring transfusions, such as cardiovascular diseases and cancer. Furthermore, technological advancements in blood collection and processing methods drive growth alongside government initiatives supporting blood donation and transfusion practices, making the U.S. a key player in this market.

Asia Pacific Blood Processing Devices and Consumables Market Trends

The Asia Pacific blood processing devices and consumables market is expected to grow at a CAGR of 9.1% from 2025 to 2030, fueled by increasing healthcare expenditures and awareness about blood donation. In addition, the expanding population and urbanization increase the demand for efficient blood processing solutions. Furthermore, the prevalence of infectious diseases necessitates better blood screening and processing technologies, driving investments in advanced medical equipment across the region.

China Blood Processing Devices and Consumables Market Trends

The blood processing devices and consumables market in China is expected to experience substantial growth over the forecast period attributed to the significant rise in chronic diseases such as diabetes and cardiovascular conditions driving the development of the blood processing market. Furthermore, the government's commitment to improving healthcare infrastructure and increasing public awareness about safe blood practices enhances demand for blood processing devices. Moreover, the growing number of hospitals and diagnostic laboratories seeking efficient blood collection and testing solutions contributes to market expansion. Innovations in technology also play a crucial role in meeting the rising healthcare needs.

Europe Blood Processing Devices and Consumables Market Trends

The Europe blood processing devices and consumables market is expected to grow significantly, owing to stringent regulations ensuring high safety and quality standards in blood collection and transfusion practices. In addition, the region’s aging population increases the demand for medical procedures requiring blood products. Furthermore, advancements in medical technology enhance operational efficiencies within hospitals and clinics. Collaborative efforts between public health organizations and private sectors to promote safe blood practices further stimulate market growth across various European countries.

The growth of the blood processing devices market in the UK is supported by strong government policies promoting safe transfusion practices and increased funding for healthcare services. In addition, the National Health Service (NHS) is pivotal in driving demand through its extensive network of hospitals requiring advanced blood processing solutions. Furthermore, rising awareness about timely diagnostics fosters greater reliance on efficient blood testing methods, contributing to an expanding market for devices and consumables in the UK healthcare system.

Key Blood Processing Devices & Consumables Company Insights

Some key global blood processing devices and consumables market companies include Biomerieux SA, Abbott, Bio-Rad Laboratories, Inc., and others. These companies adopt various strategies to maintain competitiveness. These include product innovation, focusing on advanced technologies that enhance efficiency and safety. Strategic partnerships and acquisitions allow companies to expand their product portfolios and market reach. Furthermore, investments in research and development ensure that they stay at the forefront of technological advancements, effectively meeting evolving healthcare needs and regulatory standards.

• Abbott Laboratories manufactures a range of products, including blood collection tubes, blood bags, and various reagents. The company specializes in diagnostic solutions, focusing on devices that enhance blood testing and processing efficiency and safety. Abbott's offerings cater to hospitals, clinics, and diagnostic laboratories, ensuring high-quality blood management and transfusion practices.

• Bio-Rad Laboratories, Inc. provides innovative products such as blood grouping reagents, hematology reagents, and automated blood testing systems. The company focuses on the diagnostics segment, developing solutions that improve the accuracy of blood analysis and ensure safe transfusion practices. Bio-Rad's products are widely used in clinical laboratories and hospitals, supporting effective patient care through advanced blood processing technologies.

Recent Developments

• In May 2023, Terumo BCT introduced a next-generation platform, the Spectra Optia Apheresis System. This system is designed to improve patient care and streamline workflow in blood processing. This innovative system offers advanced features that improve the efficiency of apheresis procedures, allowing for better separation of blood components. Furthermore, the platform provides essential information on contraindications and potential patient reactions to transfused blood products.

Blood Processing Devices & Consumables Market Report Scope

Global Blood Processing Devices And Consumables Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global blood processing devices and consumables market report based on product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Devices

    • Cell Processors

    • Hematocrit Centrifuges

    • Blood Bank Refrigerators

    • Blood Bank Freezers

    • Grouping Analyzers

    • Warmers

  • Consumables

    • Blood Co-agulation Reagents

    • Blood Grouping Reagents

    • Hematology Reagents

    • Blood Administration Sets

    • Sedimentation Tubes

    • Blood Bags

    • Blood Collection Tubes

    • Blood Collection Needles

    • Blood Lancets

    • Blood Filters

    • Vials

    • Slide Stainer

    • Test Tube Racks

    • Slides

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals and Clinics

  • Diagnostic Laboratories

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait